Multicenter phase II trial to investigate safety and efficacy of an adjuvant therapy with gemcitabine and cetuximab in patients with R0 or R1 resected pancreatic cancer.

Fensterer, H. and Schade-Brittinger, C. and Mueller, H. and Schupfner, B. and Fass, J. and Lindig, U. and Settmacher, U. and Ebert, M. P. and Kornmann, M. and Hofheinz, R. and Endlicher, E. and Brendel, C. and Barth, P. J. and Bartsch, D. K. and Gress, T. M. (2011) Multicenter phase II trial to investigate safety and efficacy of an adjuvant therapy with gemcitabine and cetuximab in patients with R0 or R1 resected pancreatic cancer. JOURNAL OF CLINICAL ONCOLOGY, 29 (15supp): 4039. ISSN 0732-183X, 1527-7755

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin I
Depositing User: Petra Gürster
Date Deposited: 30 Apr 2020 06:13
Last Modified: 30 Apr 2020 06:13
URI: https://pred.uni-regensburg.de/id/eprint/20806

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.